TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial to Compare Antenatal Preparation and Postnatal Counseling Strategies for Improving Breastfeeding Rates
Brief Summary: This is a randomised controlled trial to compare antenatal preparation and postnatal counseling strategies for improving breastfeeding rates.

The objectives are:

1. to study the effect of a standard two-encounter postnatal lactation counseling protocol on the initiation and maintenance of exclusive breastfeediing in mothers
2. to compare the effect of a standard two-encounter postnatal lactation counseling protocol with a single-encounter antenatal breastfeeding education protocol on the initiation and maintenance of exclusive breastfeeding in mothers.


Options:
A: Arm Label: SC + BFI; Type: EXPERIMENTAL; Interventions: Behavioral: WIC support + home-based individual support + Breastfeeding Incentives (SC+BFI) | Arm Label: SC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WIC support + home-based individual support (SC) | Intervention Type: BEHAVIORAL; Name: WIC support + home-based individual support + Breastfeeding Incentives (SC+BFI); Assigned to Arm(s): SC + BFI | Intervention Type: BEHAVIORAL; Name: WIC support + home-based individual support (SC); Assigned to Arm(s): SC
B: Intervention Type: BEHAVIORAL; Name: Lactation counseling; Assigned to Arm(s): N/A
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Breastfeeding related information delivered by WeChat | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Non-breastfeeding related information delivered by WeChat | Intervention Type: OTHER; Name: Breastfeeding related information delivered by WeChat; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Non-breastfeeding related information delivered by WeChat; Assigned to Arm(s): Control group
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Simulation breastfeeding education | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Simulation breastfeeding education; Assigned to Arm(s): Intervention Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial to Compare Antenatal Preparation and Postnatal Counseling Strategies for Improving Breastfeeding Rates
Brief Summary: This is a randomised controlled trial to compare antenatal preparation and postnatal counseling strategies for improving breastfeeding rates.

The objectives are:

1. to study the effect of a standard two-encounter postnatal lactation counseling protocol on the initiation and maintenance of exclusive breastfeediing in mothers
2. to compare the effect of a standard two-encounter postnatal lactation counseling protocol with a single-encounter antenatal breastfeeding education protocol on the initiation and maintenance of exclusive breastfeeding in mothers.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Other: Telephone Support Intervention to Improve Breastfeeding | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telephone Support Intervention to Improve Breastfeeding; Assigned to Arm(s): A
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-support for exclusive breastfeeding | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer-support for exclusive breastfeeding; Assigned to Arm(s): Intervention
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention
D: Intervention Type: BEHAVIORAL; Name: Lactation counseling; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial to Compare Antenatal Preparation and Postnatal Counseling Strategies for Improving Breastfeeding Rates
Brief Summary: This is a randomised controlled trial to compare antenatal preparation and postnatal counseling strategies for improving breastfeeding rates.

The objectives are:

1. to study the effect of a standard two-encounter postnatal lactation counseling protocol on the initiation and maintenance of exclusive breastfeediing in mothers
2. to compare the effect of a standard two-encounter postnatal lactation counseling protocol with a single-encounter antenatal breastfeeding education protocol on the initiation and maintenance of exclusive breastfeeding in mothers.


Options:
A: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral education; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral education intervention | Intervention Type: BEHAVIORAL; Name: Behavioral education intervention; Assigned to Arm(s): Behavioral education
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Infant Sleeping and Soothing | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Repeated Food Exposure | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Infant Sleeping and Soothing, Behavioral: Repeated Food Exposure | Arm Label: 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Infant Sleeping and Soothing; Assigned to Arm(s): 1, 3 | Intervention Type: BEHAVIORAL; Name: Repeated Food Exposure; Assigned to Arm(s): 2, 3
C: Arm Label: Standard well child care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Food Activity Breast feeding support; Type: EXPERIMENTAL; Interventions: Behavioral: FAB | Arm Label: Sleep; Type: EXPERIMENTAL; Interventions: Behavioral: Sleep | Arm Label: FAB + Sleep; Type: EXPERIMENTAL; Interventions: Behavioral: FAB, Behavioral: Sleep | Intervention Type: BEHAVIORAL; Name: FAB; Assigned to Arm(s): FAB + Sleep, Food Activity Breast feeding support | Intervention Type: BEHAVIORAL; Name: Sleep; Assigned to Arm(s): FAB + Sleep, Sleep
D: Intervention Type: BEHAVIORAL; Name: Lactation counseling; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: ATLAS: Ambulatory Treatments for Leakage Associated With Stress, A Randomized Trial of Pelvic Muscle Exercise Versus Incontinence Pessary Versus Both for Women With Stress or Mixed Urinary Incontinence
Brief Summary: Stress urinary incontinence is the uncontrollable leakage of urine with physical effort or stress, such as coughing, sneezing, or exercise. Treatment for stress incontinence can be surgical or non-surgical. Different non-surgical treatments include pelvic muscle exercises and pessary use. Pelvic muscle exercises (often known as "Kegel" exercises) train and strengthen the pelvic muscles and improve incontinence. A pessary is a medical device that fits inside the vagina to give the urethra and bladder extra support and prevent or reduce urinary incontinence. Exercises and pessary use can help women with stress incontinence but it is not known which treatment is better, or if a combination of the two treatments at the same time is best. This study will determine whether pelvic muscle training and exercises, pessary use, or a combination of both exercises and pessary is most effective at improving incontinence in women. The study's primary hypothesis is that pessary use is more effective than pelvic muscle exercises after 3 months of treatment.


Options:
A: Arm Label: bladdertraining group; Type: EXPERIMENTAL; Interventions: Behavioral: bladdertraining in groups | Arm Label: bladdertraining individually; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: bladdertraining individually | Intervention Type: BEHAVIORAL; Name: bladdertraining in groups; Assigned to Arm(s): bladdertraining group | Intervention Type: BEHAVIORAL; Name: bladdertraining individually; Assigned to Arm(s): bladdertraining individually
B: Arm Label: Health education intervention (HEI); Type: EXPERIMENTAL; Interventions: Behavioral: Health education intervention (HEI) | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health education intervention (HEI); Assigned to Arm(s): Health education intervention (HEI)
C: Arm Label: Intravaginal Pessary; Type: EXPERIMENTAL; Interventions: Device: Intravaginal Pessary | Arm Label: Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy | Arm Label: Pessary combined with behavioral therapy; Type: EXPERIMENTAL; Interventions: Device: Pessary combined with behavioral therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Therapy; Assigned to Arm(s): Behavioral Therapy | Intervention Type: DEVICE; Name: Intravaginal Pessary; Assigned to Arm(s): Intravaginal Pessary | Intervention Type: DEVICE; Name: Pessary combined with behavioral therapy; Assigned to Arm(s): Pessary combined with behavioral therapy
D: Arm Label: moxibustion; Type: EXPERIMENTAL; Interventions: Device: moxibustion | Arm Label: waiting; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: moxibustion; Assigned to Arm(s): moxibustion

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Naltrexone in Women's Smoking Cessation
Brief Summary: The purpose of the proposed study is to conduct a randomized, double-blind clinical trial to compare adjunct treatment with 50 mg oral naltrexone vs. placebo in conjunction with standard smoking cessation treatment with nicotine patch and counseling.

Hypotheses:

1. Naltrexone will improve smoking cessation quit rates, as measured at the end of active treatment (3 months) and during long term follow up (1 year).
2. Weight and smoking-related variables (i.e., less weight gain, as well as reduced craving and withdrawal) will be important factors by which naltrexone improves smoking cessation outcome.
3. These effects are predicted to be stronger in women compared to men.


Options:
A: Arm Label: Male Naltrexone; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone (drug) | Arm Label: Female Naltrexone; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone (drug) | Arm Label: Male Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Naltrexone) | Arm Label: Female Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Naltrexone) | Intervention Type: DRUG; Name: Naltrexone (drug); Assigned to Arm(s): Female Naltrexone, Male Naltrexone | Intervention Type: DRUG; Name: Placebo (for Naltrexone); Assigned to Arm(s): Female Placebo, Male Placebo
B: Arm Label: varenicline; Type: ACTIVE_COMPARATOR; Interventions: Drug: varenicline tartrate (CP-526, 555-18) | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: varenicline tartrate (CP-526, 555-18); Assigned to Arm(s): varenicline | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Intervention Type: DRUG; Name: varenicline (CP-526,555); Assigned to Arm(s): N/A
D: Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: varenicline; Type: EXPERIMENTAL; Interventions: Drug: Varenicline | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): varenicline

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial Comparing Anterior Colporrhaphy to Paravaginal Defect Repair for Anterior Vaginal Wall Prolapse
Brief Summary: The purpose of this study is to determine whether vaginal repair or abdominal repair is the procedure of choice for the surgical management of a prolapsed bladder.


Options:
A: Arm Label: Intervention: Collagen matrix; Type: EXPERIMENTAL; Interventions: Procedure: Collagen Matrix | Arm Label: Native tissue repair; Type: OTHER; Interventions: Procedure: Collagen Matrix | Intervention Type: PROCEDURE; Name: Collagen Matrix; Assigned to Arm(s): Intervention: Collagen matrix, Native tissue repair
B: N/A
C: Arm Label: Mesh surgery; Type: EXPERIMENTAL; Interventions: Device: Tensionfree vaginal mesh kit (Prolift) | Arm Label: Conventional vaginal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: classic vaginal prolapse surgery (fascia plication) | Intervention Type: DEVICE; Name: Tensionfree vaginal mesh kit (Prolift); Assigned to Arm(s): Mesh surgery | Intervention Type: PROCEDURE; Name: classic vaginal prolapse surgery (fascia plication); Assigned to Arm(s): Conventional vaginal surgery
D: Arm Label: Anterior colporrhaphy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Arm Label: Paravaginal defect repair; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Intervention Type: PROCEDURE; Name: anterior vaginal repair (colporrhaphy); Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair | Intervention Type: PROCEDURE; Name: abdominal paravaginal defect repair; Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial Comparing Anterior Colporrhaphy to Paravaginal Defect Repair for Anterior Vaginal Wall Prolapse
Brief Summary: The purpose of this study is to determine whether vaginal repair or abdominal repair is the procedure of choice for the surgical management of a prolapsed bladder.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Avaulta (surgical procedure using a mesh implant) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional surgery (anterior repair) | Intervention Type: PROCEDURE; Name: Avaulta (surgical procedure using a mesh implant); Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Conventional surgery (anterior repair); Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: TVT | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Other: Sham | Intervention Type: DEVICE; Name: TVT; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Sham; Assigned to Arm(s): 2
C: Arm Label: Anterior colporrhaphy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Arm Label: Paravaginal defect repair; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Intervention Type: PROCEDURE; Name: anterior vaginal repair (colporrhaphy); Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair | Intervention Type: PROCEDURE; Name: abdominal paravaginal defect repair; Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair
D: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)
Brief Summary: Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. The purpose of the REVERSE clinical trial is to determine whether pacing in both the left and right ventricles using Cardiac Resynchronization Therapy (CRT) can help slow the progression of heart failure in people who have mild or previous symptoms and poor heart pumping function. This kind of therapy has previously been shown to reduce symptoms and improve exercise capacity in people with more advanced forms of heart failure.


Options:
A: N/A
B: Arm Label: CRT OFF; Type: PLACEBO_COMPARATOR; Interventions: Device: Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT | Arm Label: CRT ON; Type: ACTIVE_COMPARATOR; Interventions: Device: Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT | Intervention Type: DEVICE; Name: Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT; Assigned to Arm(s): CRT OFF, CRT ON
C: Intervention Type: DRUG; Name: amiodarone; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: defibrillators, implantable; Assigned to Arm(s): N/A
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Device: ICD | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Other: Optimal medical treatment | Intervention Type: DEVICE; Name: ICD; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Optimal medical treatment; Assigned to Arm(s): B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Maternal Opioid Treatment: Human Experimental Research
Brief Summary: Children born to women who abuse drugs have a high risk of being born with birth defects and developmental problems. Methadone is a drug that is commonly used for treating opioid dependence. However, its use by a pregnant woman can cause severe withdrawal symptoms in a newborn because of the prenatal exposure. The purpose of this study is to evaluate the effectiveness of buprenorphine, another drug, versus methadone in reducing withdrawal symptoms in children born to opioid-dependent women.


Options:
A: Arm Label: Stochastic Vibrotactile Stimulation (SVS); Type: EXPERIMENTAL; Interventions: Device: Stochastic Vibrotactile Stimulation (SVS) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Stochastic Vibrotactile Stimulation (SVS); Assigned to Arm(s): Stochastic Vibrotactile Stimulation (SVS)
B: Arm Label: Clonidine; Type: EXPERIMENTAL; Interventions: Drug: Clonidine | Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine Sulfate | Intervention Type: DRUG; Name: Clonidine; Assigned to Arm(s): Clonidine | Intervention Type: DRUG; Name: Morphine Sulfate; Assigned to Arm(s): Morphine
C: Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone
D: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Maternal Opioid Treatment: Human Experimental Research
Brief Summary: Children born to women who abuse drugs have a high risk of being born with birth defects and developmental problems. Methadone is a drug that is commonly used for treating opioid dependence. However, its use by a pregnant woman can cause severe withdrawal symptoms in a newborn because of the prenatal exposure. The purpose of this study is to evaluate the effectiveness of buprenorphine, another drug, versus methadone in reducing withdrawal symptoms in children born to opioid-dependent women.


Options:
A: Arm Label: Stochastic Vibrotactile Stimulation (SVS); Type: EXPERIMENTAL; Interventions: Device: Stochastic Vibrotactile Stimulation (SVS) | Arm Label: Treatment as Usual (TAU); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Stochastic Vibrotactile Stimulation (SVS); Assigned to Arm(s): Stochastic Vibrotactile Stimulation (SVS)
B: Arm Label: Phenobarbital; Type: EXPERIMENTAL; Interventions: Drug: Phenobarbital | Arm Label: Chlorpromazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorpromazine | Arm Label: Morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine | Intervention Type: DRUG; Name: Phenobarbital; Assigned to Arm(s): Phenobarbital | Intervention Type: DRUG; Name: Chlorpromazine; Assigned to Arm(s): Chlorpromazine | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine
C: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
D: Arm Label: Oral morphine solution; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral morphine solution | Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: buprenorphine | Intervention Type: DRUG; Name: buprenorphine; Assigned to Arm(s): Buprenorphine | Intervention Type: DRUG; Name: Oral morphine solution; Assigned to Arm(s): Oral morphine solution

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Maternal Opioid Treatment: Human Experimental Research
Brief Summary: Children born to women who abuse drugs have a high risk of being born with birth defects and developmental problems. Methadone is a drug that is commonly used for treating opioid dependence. However, its use by a pregnant woman can cause severe withdrawal symptoms in a newborn because of the prenatal exposure. The purpose of this study is to evaluate the effectiveness of buprenorphine, another drug, versus methadone in reducing withdrawal symptoms in children born to opioid-dependent women.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine/naloxone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): 2
B: Intervention Type: DRUG; Name: Buprenorphine/Subutex; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Drug counseling; Assigned to Arm(s): N/A
C: Arm Label: Buprenorphine; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine; Assigned to Arm(s): Buprenorphine
D: Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): N/A

Answer: C